A PSEN1 genetic test looks for mutations in the presenilin 1 gene, the single most common known cause of early-onset familial Alzheimer disease. Before a younger adult with memory problems agrees to the test, the questions worth asking cover why the test is being offered, what a result would mean, and who should be in the room for the decision. PSEN1 pathogenic variants account for roughly 30% to 70% of early-onset familial Alzheimer cases, which is why NIH GeneReviews identifies it as the gene clinicians typically test first. That makes it a reasonable starting point for someone with memory loss and a strong family history, but it is not a general screening tool, and understanding its limits matters as much as understanding what it can find.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Is this the right test for my situation?
- What does a positive result actually tell me?
- What does a negative result actually rule out?
- What should happen before and after the test?
- Frequently Asked Questions
Is this the right test for my situation?
PSEN1 testing comes in two distinct forms, and confusing them leads to the wrong expectations. Diagnostic testing is for a symptomatic adult who already has memory problems and a strong multigenerational family history of early-onset dementia. Predictive, or presymptomatic, testing is for a healthy adult relative of someone already confirmed to carry a PSEN1 mutation. According to ARUP Laboratories and pathologytestsexplained.org.au, the test is not useful as a population-wide screen and does not apply to typical late-onset Alzheimer's, which usually appears after age 65 and has different genetic drivers.
Ask directly which category applies: a diagnostic workup for symptoms already present, or a predictive test prompted by a relative's confirmed result. The reasoning, counseling, and emotional stakes differ between the two. Insurers also distinguish between them. Highmark's medical policy typically requires predictive testing candidates to be at least 18 years old, to have no prior test for the same variant, and to have a first- or second-degree biological relative with a confirmed PSEN1, PSEN2, or APP mutation. A person without that family link is unlikely to meet coverage criteria for predictive testing.
What does a positive result actually tell me?
A positive PSEN1 result carries more certainty than most genetic findings. PSEN1 mutations show essentially complete penetrance in people who reach a normal lifespan, meaning nearly all carriers eventually develop symptoms, according to the clinical review cited in Highmark's policy. That compares with about 95% penetrance for PSEN2 mutations, so a PSEN1 finding leaves less room for uncertainty about whether symptoms will eventually appear. Ask about timing, not just certainty.
Data from the Dominantly Inherited Alzheimer Network shows that PSEN1 carriers tend to develop the earliest and most aggressive onset among the known Alzheimer's genes, often starting before age 45, frequently in the late 30s to mid-40s. Onset age tends to track closely with other affected relatives in the same family, so a genetic counselor can often give a rough window based on family history rather than a generic age range. Ask too about family planning implications. A PSEN1 mutation follows an autosomal dominant inheritance pattern, so according to Lab Tests Online UK, each biological child of a carrier has a 50% chance of inheriting it, regardless of the parent's or child's sex. This is often the question that matters most to someone in their 30s or 40s who is still raising children or considering having more.
What does a negative result actually rule out?
A negative result is reassuring but not conclusive, and the distinction matters most for someone who already has symptoms. For a person with diagnosed early-onset Alzheimer's, disease-causing variants across PSEN1, PSEN2, and APP combined are found in only about 60% to 80% of cases, according to ARUP Laboratories. That means a negative result on these three genes does not rule out a genetic cause; it may simply mean the cause lies in a gene not yet tested or not yet identified. Ask specifically which genes were included in the panel and whether a negative result changes the diagnostic workup.
A negative predictive test in a healthy relative is more informative, since it means that specific family mutation was not inherited, but it does not erase the general population risk of dementia from other causes. Ask about the emotional aftermath too. In a peer-reviewed follow-up study tracked in PMC, people who tested negative for a familial Alzheimer's mutation reported testing-specific psychological distress a year later at a level similar to those who tested positive. A negative result does not automatically resolve anxiety, and that is worth discussing before the blood draw, not after.
What should happen before and after the test?
Genetic counseling before and after PSEN1 testing is a standard requirement, not an optional add-on, particularly for predictive testing in a healthy relative. Highmark's medical policy specifies that a qualified provider should review the implications of both a positive and a negative result before testing proceeds.
Ask who that counselor will be, whether they specialize in neurogenetic conditions, and what the post-result session will cover. Useful questions to bring into that counseling conversation: Ask about sequencing with other relatives too. Because PSEN1 is inherited in a dominant pattern, a confirmed mutation in one relative changes the stakes for siblings, children, and parents, and a counselor can help decide who should be tested, and in what order, rather than everyone testing at once.
- What exactly will this result change about my medical care or planning?
- Who else in my family needs to know, and when?
- What support is available if the result is positive — financial planning, long-term care, clinical trials?
- What support is available if the result is negative but distress persists?
- Does my insurance cover this test, and does it meet the age and family-history requirements the insurer sets?
Frequently Asked Questions
Can a PSEN1 test be used as a general screening tool for anyone with memory problems?
No. It is intended for a symptomatic adult with a strong multigenerational family history of early-onset dementia, or a healthy relative of a confirmed carrier, not as a population-wide screen.
Does a negative PSEN1 result mean memory problems aren't genetic?
Not necessarily. Among people who already have early-onset Alzheimer's, PSEN1, PSEN2, and APP combined explain only about 60% to 80% of cases, so a negative result can leave a genetic cause unidentified.
Will insurance cover predictive PSEN1 testing for a healthy adult?
Coverage criteria typically require the person to be at least 18, have no prior test for the same variant, and have a first- or second-degree relative with a confirmed PSEN1, PSEN2, or APP mutation.
